SlideShare uma empresa Scribd logo
1 de 45
“Dynamics of the Interaction Between
 the Human Gut Microbiome and Immune System”


                         Discussion
         Janssen La Jolla Research and Development
                         La Jolla, CA
                     February 22, 2013


                             Dr. Larry Smarr
Director, California Institute for Telecommunications and Information
                                Technology
                       Harry E. Gruber Professor,
             Dept. of Computer Science and Engineering
                                                                        1
                 Jacobs School of Engineering, UCSD
From Measuring Macro-Variables
to Measuring Your Internal Variables




  www.technologyreview.com/biomedicine/39636
From One to a Billion Data Points Defining Me:
The Exponential Rise in Body Data in Just One Decade!

                                                   Billion:Microbial Genome
                                                           My Full DNA,
                                                      MRI/CT Images




              Improving Body
                                              SNPs
                          Million: My DNA SNPs,
                                 Zeo, FitBit
                                               Discovering Disease
                        Blood
                       Variables

             One:                  Hundred: My Blood Variables
       Weight Weight
          My
Visualizing Time Series of
150 LS Blood and Stool Variables, Each Over 5 Years
                                 Calit2 64 megapixel VROOM
Complex Reactive Protein
                From Blood Sample
                                         27x Upper Limit
      Peak Sec IgA, Lysozyme 1/30/12
      Peak CRP, Calprotectin 12/28/11
      Peak Lactoferrin 5/2/11




      Normal Range
        <1 mg/L
Antibiotics



                                        Antibiotics
                                                Normal
Lactoferrin
                From Stool Sample
                                     124x Upper Limit




   Peak Sec IgA, Lysozyme 1/30/12
   Peak CRP, Calprotectin 12/28/11
   Peak Lactoferrin 5/2/11


              Normal Range                        Antibiotics
               <7.3 µg/mL


Antibiotics
High Lactoferrin Biomarker Led Me to Hypothesis
     I Had Inflammatory Bowel Disease (IBD)
  IBD is an Autoimmune Disease Which Comes in Two Subtypes:
                  Crohn’s and Ulcerative Colitis

       Scand J Gastroenterol.
          42, 1440-4 (2007)

       My Values May 2011




      My Values 2009-10




               High Level of Calprotectin
                 Confirmed Hypothesis
Colonoscopy Images Show
           Sigmoid Colon Inflammation




Dec 2010

                              May 2011
Confirming the IBD (Crohn’s) Hypothesis:
         Finding the “Smoking Gun” with MRI Imaging
      Liver                              I Obtained the MRI Slices
                  Transverse Colon
                                       From UCSD Medical Services
                                      and Converted to Interactive 3D
                                                Working With
         Small Intestine              Calit2 Staff & DeskVOX Software
                                                                  Descending Colon




 MRI Jan 2012
Cross Section
                  Diseased Sigmoid Colon




                                                                       Major Kink
                                               Sigmoid Colon
                                           Threading Iliac Arteries
Comparison of DeskVOX with
 Clinical MRI Slice Program
Interactively Exploring My Body
            With Calit2 Virtual Reality Facilities
                                                                       TourCAVE

                              StarCAVE




                                                                     VROOM



www.youtube.com/watch?v=9c4DtJ_L_Ps

         zSpace




         Photo & CalVR software Courtesy of Jurgen Schulze, Calit2
Connecting Colonoscopy “Inside View”
      With MRI “Outside View”




    LS Colon Images and Colonoscopy Video
   On Calit2 Director’s Colony OptIPortable Wall
Why Did I Have an Autoimmune Disease like IBD?


      Despite decades of research,
     the etiology of Crohn's disease
            remains unknown.
      Its pathogenesis may involve
      a complex interplay between
              host genetics,
           immune dysfunction,
  and microbial or environmental factors.
      --The Role of Microbes in Crohn's Disease

     So I Set Out to Quantify All Three!
             Paul B. Eckburg & David A. Relman
              Clin Infect Dis. 44:256-262 (2007) 
I Wondered if Crohn’s is an Autoimmune Disease,
  Did I Have a Personal Genomic Polymorphism?
            From www.23andme.com            Polymorphism in
                                     Interleukin-23 Receptor Gene
                                          — 80% Higher Risk
             ATG16L1
                                          of Pro-inflammatory
                                           Immune Response
                   IRGM




     NOD2        SNPs Associated with CD


                                               Now Comparing
                                            163 Known IBD SNPs
                                           with 23andme SNP Chip
Crohn’s May be a Related Set of Diseases
        Driven by Different SNPs

    NOD2 (1)
   rs2066844
                                        Female
                                       CD Onset
                                    At 20-Years Old




                                    Il-23R
                                  rs1004819



                                        Me-Male
                                       CD Onset
                                    At 60-Years Old
White Blood Cell Count
 From Blood Sample
                  Peak Sec IgA, Lysozyme 1/30/12
                  Peak CRP, Calprotectin 12/28/11
                  Peak Lactoferrin 5/2/11


           Normal Range
          4-10,000 cells/µL
      Normal
                                  Antibiotics
Neutrophils as % of WBCs
    From Blood Sample




    Normal Range
       31-71%
Normal
                   Peak Sec IgA, Lysozyme 1/30/12
                   Peak CRP, Calprotectin 12/28/11
                   Peak Lactoferrin 5/2/11
Lymphocytes as % of WBCs
           From Blood Sample

                       Peak Sec IgA, Lysozyme 1/30/12
                       Peak CRP, Calprotectin 12/28/11
                       Peak Lactoferrin 5/2/11


             Normal




                                                            Antibiotics




Lymphocytes Include B Cells, T cells, and Natural Killer Cells
Eosinophils as % of WBCs
             From Blood

           Peak Sec IgA, Lysozyme 1/30/12
           Peak CRP, Calprotectin 12/28/11
           Peak Lactoferrin 5/2/11




                                                   Normal
Normal Range
    1-7%
                                     Antibiotics
Monocytes as % of WBCs
               From Blood

              Peak Sec IgA, Lysozyme 1/30/12
              Peak CRP, Calprotectin 12/28/11
              Peak Lactoferrin 5/2/11
Normal
   Normal Range
      5-12%
Calprotectin
                From Stool Sample
                                    50x Upper Limit




Peak Sec IgA, Lysozyme 1/30/12
Peak CRP, Calprotectin 12/28/11
Peak Lactoferrin 5/2/11

                                             Normal Range
                                               <50 µg/g

                                               Antibiotics
Secretory IgA
                   From Stool Sample
                                                7x Upper Limit
              Peak Sec IgA, Lysozyme 1/30/12
              Peak CRP, Calprotectin 12/28/11
              Peak Lactoferrin 5/2/11


                                                       Antibiotics




Antibiotics         Normal Range
                    54-204 mg/dL
                                                             Normal
Lysozyme
                     From Stool Sample
                                                2x Upper Limit
Antibiotics                                         Antibiotics
              Peak Sec IgA, Lysozyme 1/30/12
              Peak CRP, Calprotectin 12/28/11
              Peak Lactoferrin 5/2/11




                                           Normal

                                                         Normal Range
                                                          <600 ng/mL
Putting Multiple Immunological Biomarker Time Series
     Together, Reveals Major Immune Dysfunction




     Green : Inside Range
     Orange: 1-10x Over
     Red: 10-100x Over
     Purple: >100x Over




               Source: Calit2 Future Health Expedition Team
Four Immune Biomarkers Over Time
 Compared with Four Signs/Symptoms




Here Immune biomarkers are normalized 0 to 1,
  with 1 being the highest value in five years



      Source: Photo of Calit2 64-megapixel VROOM
Microbes are 90% of Your Cells-So I Set Out
to Determine My Gut Microbes & Their Time Variation
                              Shipped Stool Sample
                               December 28, 2011

                                    I Received
                             a Disk Drive April 3, 2012
                             With 35 GB FASTQ Files

                               Weizhong Li, UCSD
                                 NGS Pipeline:
                                  230M Reads
                               Only 0.2% Human

                           Required 1/2 cpu-yr at SDSC
                              Per Person Analyzed!
First Surprise:
Almost All My DNA Abundances are Viral!
LS Viral Species Comprise >97%
Relative Abundance of Virus + Bacteria + Archaea

                         LS Virus Species Which Are
                         >1% of Total Abundance

                         In an Average Healthy Person,
                         None of LS Viruses Exceed 0.01%
                         of the Total Relative Abundance of
                         Viruses + Bacteria

                         In Average Healthy Person, Viruses
                         Are <2% of Total Abundance
My Viral Load is Mainly SP-6 Like
What is a “Healthy” Gut Microbiome?
       Considerable Phyla Variation Found in HMP




Note: Euryarchaeota Are So Rare
   That They Arent Graphed!




         Source: “Structure, function and diversity of the healthy human
           microbiome,” HMP Consortium, Nature, 486, 207-212 (2012)
Phyla Gut Microbial Abundance Without Viruses:
          LS, Crohn’s, UC, and Healthy Subjects
          Source: Weizhong Li, UCSD; Calit2 FuturePatient Expedition




LS      Crohn’s      Ulcerative                   Healthy
                      Colitis

                       Toward Noninvasive
                   Microbial Ecology Diagnostics
LS Time Series Gut Microbiome Classes
 vs. Healthy, Crohn’s, Ulcerative Colitis
Microbial Metagenomics Can Diagnose Disease States
        Using Principal Component Analysis
           From www.23andme.com
                                      Mutation in Interleukin-23
                                     Receptor Gene—80% Higher
                                      Risk of Pro-inflammatory
                                         Immune Response


                                                IBD Patients Harbored,
                                                      on Average,
                                                      25% Fewer
               SNPs Associated with CD
                                                    Microbial Genes
                                                  than the Individuals
                                                Not Suffering from IBD.




                                2009
Principal Component Analysis
On Microbial Species Abundance
Healthy, CD, UC and LS
Relative Abundance of Proteobacteria to Actinobacteria
Bacteroides fragilis Levels Different For
Healthy and IBD Human Gut-Differentiates CD and UC

                                           Healthy
                       Ulcerative
                        Colitis

   LS    Crohn’s
         Disease




         Source: Analysis by LS working on Weizhong Li Data
Almost All Abundant Species (≥1%) in Healthy Subjects
           Are Severely Depleted in LS Gut
Top 20 Most Abundant Microbial Species
   In LS vs. Average Healthy Subject
152x                                            Number Above
                                             LS Blue Bar is Multiple
                                               of LS Abundance
   765x
                                             Compared to Average
       148x                                   Healthy Abundance
                                                  Per Species
          849x
             483x
                220x
                  201x169x
                         522x




  Source: Sequencing JCVI; Analysis Weizhong Li, UCSD
           LS December 28, 2011 Stool Sample
Comparing 3 LS Time Snapshots (Left)
with Healthy, Crohn’s, UC (Right Top to Bottom)




           Calit2 VROOM-FuturePatient Expedition
LS Gut Microbe Species 12/28/11 (red)
compared to Average of 35 Healthy Subjects (blue)




Derived from metagenomic sequencing of LS stool sample.
                  Each species is a bar,
             height is logarithmic abundance,
          species are divided into microbial phyla
           Source: Photo of Calit2 64-megapixel VROOM
200 LS Gut Microbe Species at 3 Times
              12/28/11, 4/3/12, 8/7/12




              Red is at Highest Value of CRP
Blue is the Day After End of Antibiotic/Prednisone Therapy
                Green is Four Months Later

            Source: Photo of Calit2 64-megapixel VROOM
Closeup of Uncommon LS Microbes
                12/28/11 Stool Sample
                                              Two separate
  45x                                        research teams
Reduced                                         have found
                                               strikingly high
  By              8%              90x         concentrations
Therapy        Increased        Reduced     of Fusobacterium
                                            in tumor samples
                  By              By          collected from
                Therapy         Therapy     colorectal cancer
                                                  patients.
                                            October 18, 2011
From War
      to Gardening




  “I would like to lose the language of warfare,”
     said Julie Segre, a senior investigator at
the National Human Genome Research Institute.
      ”It does a disservice to all the bacteria
            that have co-evolved with us
  and are maintaining the health of our bodies.”
DIY Systems Biology -
                                    Toward P4 Healthcare

                                                                 Over 1000 Downloads So Far




         Download pdfs from Journal:
http://onlinelibrary.wiley.com/doi/10.1002/biot.201100495/full
Integrative Personal Omics Profiling
Reveals Details of Clinical Onset of Viruses and Diabetes
                                    Cell 148, 1293–1307, March 16, 2012

                                          •   Michael Snyder,
                                              Chair of Genomics
                                              Stanford Univ.
                                          •   Genome 140x
                                              Coverage
                                          •   Blood Tests 20
                                              Times in 14 Months
                                               – tracked nearly
                                                 20,000 distinct
                                                 transcripts coding
                                                 for 12,000 genes
                                               – measured the
                                                 relative levels of
                                                 more than 6,000
                                                 proteins and 1,000
                                                 metabolites in
                                                 Snyder's blood

Mais conteúdo relacionado

Mais procurados

Quantifying and Visualizing the State of Your Body
Quantifying and Visualizing the State of Your BodyQuantifying and Visualizing the State of Your Body
Quantifying and Visualizing the State of Your BodyLarry Smarr
 
Biopharmaceutical Manufacturing Introduction
Biopharmaceutical Manufacturing IntroductionBiopharmaceutical Manufacturing Introduction
Biopharmaceutical Manufacturing IntroductionScott M. Wheelwright, PhD
 
60 ch14dn ahistory2008
60 ch14dn ahistory200860 ch14dn ahistory2008
60 ch14dn ahistory2008sbarkanic
 
Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...
Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...
Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...Copenhagenomics
 
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...Quality Assistance s.a.
 
Monoclonal antibodies stem cell 2018
Monoclonal antibodies stem cell 2018Monoclonal antibodies stem cell 2018
Monoclonal antibodies stem cell 2018Ahmed Abdellatif
 
Research poster 2015
Research poster 2015Research poster 2015
Research poster 2015Sheila Njau
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technologyilo0lo0
 
13 genetic engineering bw
13 genetic engineering bw13 genetic engineering bw
13 genetic engineering bwhoney444
 
Genetic engineering and biotechnology 2016
Genetic engineering and biotechnology 2016Genetic engineering and biotechnology 2016
Genetic engineering and biotechnology 2016Dobbs Ferry High School
 
4.4 genetic engineering & biotechnology
4.4 genetic engineering & biotechnology4.4 genetic engineering & biotechnology
4.4 genetic engineering & biotechnologycartlidge
 
Stem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinyaStem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinyaraditio ghifiardi
 
Sergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord Blood
Sergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord BloodSergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord Blood
Sergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord BloodSingapore Society for Haematology
 
principle and applications of recombinant DNA technology
principle and applications of recombinant DNA technologyprinciple and applications of recombinant DNA technology
principle and applications of recombinant DNA technologylovely professional university
 
Recombinant DNA technology
Recombinant DNA technologyRecombinant DNA technology
Recombinant DNA technologyTapeshwar Yadav
 

Mais procurados (20)

Quantifying and Visualizing the State of Your Body
Quantifying and Visualizing the State of Your BodyQuantifying and Visualizing the State of Your Body
Quantifying and Visualizing the State of Your Body
 
5160
51605160
5160
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Biopharmaceutical Manufacturing Introduction
Biopharmaceutical Manufacturing IntroductionBiopharmaceutical Manufacturing Introduction
Biopharmaceutical Manufacturing Introduction
 
60 ch14dn ahistory2008
60 ch14dn ahistory200860 ch14dn ahistory2008
60 ch14dn ahistory2008
 
Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...
Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...
Discovery of Cow Rumen Biomass-Degrading Genes and Genomes through DNA Sequen...
 
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...
 
Monoclonal antibodies stem cell 2018
Monoclonal antibodies stem cell 2018Monoclonal antibodies stem cell 2018
Monoclonal antibodies stem cell 2018
 
Research poster 2015
Research poster 2015Research poster 2015
Research poster 2015
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
13 genetic engineering bw
13 genetic engineering bw13 genetic engineering bw
13 genetic engineering bw
 
R dna technology
R dna  technologyR dna  technology
R dna technology
 
Genetic engineering and biotechnology 2016
Genetic engineering and biotechnology 2016Genetic engineering and biotechnology 2016
Genetic engineering and biotechnology 2016
 
4.4 genetic engineering & biotechnology
4.4 genetic engineering & biotechnology4.4 genetic engineering & biotechnology
4.4 genetic engineering & biotechnology
 
Stem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinyaStem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinya
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Sergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord Blood
Sergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord BloodSergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord Blood
Sergio Querol - Advances in UCBT: UCB Banking, Making the Most of Cord Blood
 
Genetic engineering
Genetic engineeringGenetic engineering
Genetic engineering
 
principle and applications of recombinant DNA technology
principle and applications of recombinant DNA technologyprinciple and applications of recombinant DNA technology
principle and applications of recombinant DNA technology
 
Recombinant DNA technology
Recombinant DNA technologyRecombinant DNA technology
Recombinant DNA technology
 

Semelhante a Dynamics of the Interaction Between the Human Gut Microbiome and Immune System

Personal Data Tracking and the Digital Transformation of Healthcare
Personal Data Tracking and the Digital Transformation of HealthcarePersonal Data Tracking and the Digital Transformation of Healthcare
Personal Data Tracking and the Digital Transformation of HealthcareLarry Smarr
 
Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...
Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...
Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...Larry Smarr
 
Deep Self - Quantifying the State of Your Body
Deep Self - Quantifying the State of Your BodyDeep Self - Quantifying the State of Your Body
Deep Self - Quantifying the State of Your BodyLarry Smarr
 
Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body
Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism BodyUsing Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body
Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism BodyLarry Smarr
 
My N=1 Experience
My N=1 ExperienceMy N=1 Experience
My N=1 ExperienceLarry Smarr
 
Quantifying My Body: The Role of the Human and Microbiome DNA
Quantifying My Body:The Role of the Human and Microbiome DNAQuantifying My Body:The Role of the Human and Microbiome DNA
Quantifying My Body: The Role of the Human and Microbiome DNALarry Smarr
 
Quantifying Your Superorganism Body Using Big Data Supercomputing
Quantifying Your Superorganism Body Using Big Data SupercomputingQuantifying Your Superorganism Body Using Big Data Supercomputing
Quantifying Your Superorganism Body Using Big Data SupercomputingLarry Smarr
 
Digitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism BodyDigitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism BodyLarry Smarr
 
Discovering Yourself with Computational Bioinformatics
Discovering Yourself with Computational BioinformaticsDiscovering Yourself with Computational Bioinformatics
Discovering Yourself with Computational BioinformaticsLarry Smarr
 
Towards Digitally Enabled Genomic Medicine: the Patient of The Future
Towards Digitally Enabled Genomic Medicine: the Patient of The FutureTowards Digitally Enabled Genomic Medicine: the Patient of The Future
Towards Digitally Enabled Genomic Medicine: the Patient of The FutureLarry Smarr
 
Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...
Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...
Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...Larry Smarr
 
Supercomputing Your Inner Microbiome
Supercomputing Your Inner MicrobiomeSupercomputing Your Inner Microbiome
Supercomputing Your Inner MicrobiomeLarry Smarr
 
Supercomputing Your Inner Microbiome
Supercomputing Your Inner MicrobiomeSupercomputing Your Inner Microbiome
Supercomputing Your Inner MicrobiomeNicole McLaughlin
 
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...Larry Smarr
 
Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...
Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...
Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...Larry Smarr
 
Discovering the Other 90% of our Human Superorganism
Discovering the Other 90% of our Human SuperorganismDiscovering the Other 90% of our Human Superorganism
Discovering the Other 90% of our Human SuperorganismLarry Smarr
 
Capturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome SystemCapturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome SystemLarry Smarr
 
Using Supercomputers and Gene Sequencers to Discover Your Inner Microbiome
Using Supercomputers and Gene Sequencers to Discover Your Inner MicrobiomeUsing Supercomputers and Gene Sequencers to Discover Your Inner Microbiome
Using Supercomputers and Gene Sequencers to Discover Your Inner MicrobiomeLarry Smarr
 
Be Your Own Health Detective
Be Your Own Health DetectiveBe Your Own Health Detective
Be Your Own Health DetectiveLarry Smarr
 
Big Data and Superorganism Genomics: Microbial Metagenomics Meets Human Genomics
Big Data and Superorganism Genomics: Microbial Metagenomics Meets Human GenomicsBig Data and Superorganism Genomics: Microbial Metagenomics Meets Human Genomics
Big Data and Superorganism Genomics: Microbial Metagenomics Meets Human GenomicsLarry Smarr
 

Semelhante a Dynamics of the Interaction Between the Human Gut Microbiome and Immune System (20)

Personal Data Tracking and the Digital Transformation of Healthcare
Personal Data Tracking and the Digital Transformation of HealthcarePersonal Data Tracking and the Digital Transformation of Healthcare
Personal Data Tracking and the Digital Transformation of Healthcare
 
Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...
Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...
Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Croh...
 
Deep Self - Quantifying the State of Your Body
Deep Self - Quantifying the State of Your BodyDeep Self - Quantifying the State of Your Body
Deep Self - Quantifying the State of Your Body
 
Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body
Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism BodyUsing Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body
Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body
 
My N=1 Experience
My N=1 ExperienceMy N=1 Experience
My N=1 Experience
 
Quantifying My Body: The Role of the Human and Microbiome DNA
Quantifying My Body:The Role of the Human and Microbiome DNAQuantifying My Body:The Role of the Human and Microbiome DNA
Quantifying My Body: The Role of the Human and Microbiome DNA
 
Quantifying Your Superorganism Body Using Big Data Supercomputing
Quantifying Your Superorganism Body Using Big Data SupercomputingQuantifying Your Superorganism Body Using Big Data Supercomputing
Quantifying Your Superorganism Body Using Big Data Supercomputing
 
Digitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism BodyDigitally Revealing the Dynamics of Your Superorganism Body
Digitally Revealing the Dynamics of Your Superorganism Body
 
Discovering Yourself with Computational Bioinformatics
Discovering Yourself with Computational BioinformaticsDiscovering Yourself with Computational Bioinformatics
Discovering Yourself with Computational Bioinformatics
 
Towards Digitally Enabled Genomic Medicine: the Patient of The Future
Towards Digitally Enabled Genomic Medicine: the Patient of The FutureTowards Digitally Enabled Genomic Medicine: the Patient of The Future
Towards Digitally Enabled Genomic Medicine: the Patient of The Future
 
Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...
Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...
Using Supercomputers to Discover the 100 Trillion Bacteria Living Within Each...
 
Supercomputing Your Inner Microbiome
Supercomputing Your Inner MicrobiomeSupercomputing Your Inner Microbiome
Supercomputing Your Inner Microbiome
 
Supercomputing Your Inner Microbiome
Supercomputing Your Inner MicrobiomeSupercomputing Your Inner Microbiome
Supercomputing Your Inner Microbiome
 
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
 
Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...
Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...
Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorecta...
 
Discovering the Other 90% of our Human Superorganism
Discovering the Other 90% of our Human SuperorganismDiscovering the Other 90% of our Human Superorganism
Discovering the Other 90% of our Human Superorganism
 
Capturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome SystemCapturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome System
 
Using Supercomputers and Gene Sequencers to Discover Your Inner Microbiome
Using Supercomputers and Gene Sequencers to Discover Your Inner MicrobiomeUsing Supercomputers and Gene Sequencers to Discover Your Inner Microbiome
Using Supercomputers and Gene Sequencers to Discover Your Inner Microbiome
 
Be Your Own Health Detective
Be Your Own Health DetectiveBe Your Own Health Detective
Be Your Own Health Detective
 
Big Data and Superorganism Genomics: Microbial Metagenomics Meets Human Genomics
Big Data and Superorganism Genomics: Microbial Metagenomics Meets Human GenomicsBig Data and Superorganism Genomics: Microbial Metagenomics Meets Human Genomics
Big Data and Superorganism Genomics: Microbial Metagenomics Meets Human Genomics
 

Mais de Larry Smarr

My Remembrances of Mike Norman Over The Last 45 Years
My Remembrances of Mike Norman Over The Last 45 YearsMy Remembrances of Mike Norman Over The Last 45 Years
My Remembrances of Mike Norman Over The Last 45 YearsLarry Smarr
 
Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019
Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019
Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019Larry Smarr
 
Panel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving InstitutionsPanel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving InstitutionsLarry Smarr
 
Global Network Advancement Group - Next Generation Network-Integrated Systems
Global Network Advancement Group - Next Generation Network-Integrated SystemsGlobal Network Advancement Group - Next Generation Network-Integrated Systems
Global Network Advancement Group - Next Generation Network-Integrated SystemsLarry Smarr
 
Wireless FasterData and Distributed Open Compute Opportunities and (some) Us...
 Wireless FasterData and Distributed Open Compute Opportunities and (some) Us... Wireless FasterData and Distributed Open Compute Opportunities and (some) Us...
Wireless FasterData and Distributed Open Compute Opportunities and (some) Us...Larry Smarr
 
Panel Discussion: Engaging underrepresented technologists, researchers, and e...
Panel Discussion: Engaging underrepresented technologists, researchers, and e...Panel Discussion: Engaging underrepresented technologists, researchers, and e...
Panel Discussion: Engaging underrepresented technologists, researchers, and e...Larry Smarr
 
The Asia Pacific and Korea Research Platforms: An Overview Jeonghoon Moon
The Asia Pacific and Korea Research Platforms: An Overview Jeonghoon MoonThe Asia Pacific and Korea Research Platforms: An Overview Jeonghoon Moon
The Asia Pacific and Korea Research Platforms: An Overview Jeonghoon MoonLarry Smarr
 
Panel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving InstitutionsPanel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving InstitutionsLarry Smarr
 
Panel: The Global Research Platform: An Overview
Panel: The Global Research Platform: An OverviewPanel: The Global Research Platform: An Overview
Panel: The Global Research Platform: An OverviewLarry Smarr
 
Panel: Future Wireless Extensions of Regional Optical Networks
Panel: Future Wireless Extensions of Regional Optical NetworksPanel: Future Wireless Extensions of Regional Optical Networks
Panel: Future Wireless Extensions of Regional Optical NetworksLarry Smarr
 
Global Research Platform Workshops - Maxine Brown
Global Research Platform Workshops - Maxine BrownGlobal Research Platform Workshops - Maxine Brown
Global Research Platform Workshops - Maxine BrownLarry Smarr
 
Built around answering questions
Built around answering questionsBuilt around answering questions
Built around answering questionsLarry Smarr
 
Panel: NRP Science Impacts​
Panel: NRP Science Impacts​Panel: NRP Science Impacts​
Panel: NRP Science Impacts​Larry Smarr
 
Democratizing Science through Cyberinfrastructure - Manish Parashar
Democratizing Science through Cyberinfrastructure - Manish ParasharDemocratizing Science through Cyberinfrastructure - Manish Parashar
Democratizing Science through Cyberinfrastructure - Manish ParasharLarry Smarr
 
Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;
Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;
Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;Larry Smarr
 
Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...
Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...
Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...Larry Smarr
 
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Larry Smarr
 
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Larry Smarr
 
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Larry Smarr
 
Frank Würthwein - NRP and the Path forward
Frank Würthwein - NRP and the Path forwardFrank Würthwein - NRP and the Path forward
Frank Würthwein - NRP and the Path forwardLarry Smarr
 

Mais de Larry Smarr (20)

My Remembrances of Mike Norman Over The Last 45 Years
My Remembrances of Mike Norman Over The Last 45 YearsMy Remembrances of Mike Norman Over The Last 45 Years
My Remembrances of Mike Norman Over The Last 45 Years
 
Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019
Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019
Metagenics How Do I Quantify My Body and Try to Improve its Health? June 18 2019
 
Panel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving InstitutionsPanel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving Institutions
 
Global Network Advancement Group - Next Generation Network-Integrated Systems
Global Network Advancement Group - Next Generation Network-Integrated SystemsGlobal Network Advancement Group - Next Generation Network-Integrated Systems
Global Network Advancement Group - Next Generation Network-Integrated Systems
 
Wireless FasterData and Distributed Open Compute Opportunities and (some) Us...
 Wireless FasterData and Distributed Open Compute Opportunities and (some) Us... Wireless FasterData and Distributed Open Compute Opportunities and (some) Us...
Wireless FasterData and Distributed Open Compute Opportunities and (some) Us...
 
Panel Discussion: Engaging underrepresented technologists, researchers, and e...
Panel Discussion: Engaging underrepresented technologists, researchers, and e...Panel Discussion: Engaging underrepresented technologists, researchers, and e...
Panel Discussion: Engaging underrepresented technologists, researchers, and e...
 
The Asia Pacific and Korea Research Platforms: An Overview Jeonghoon Moon
The Asia Pacific and Korea Research Platforms: An Overview Jeonghoon MoonThe Asia Pacific and Korea Research Platforms: An Overview Jeonghoon Moon
The Asia Pacific and Korea Research Platforms: An Overview Jeonghoon Moon
 
Panel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving InstitutionsPanel: Reaching More Minority Serving Institutions
Panel: Reaching More Minority Serving Institutions
 
Panel: The Global Research Platform: An Overview
Panel: The Global Research Platform: An OverviewPanel: The Global Research Platform: An Overview
Panel: The Global Research Platform: An Overview
 
Panel: Future Wireless Extensions of Regional Optical Networks
Panel: Future Wireless Extensions of Regional Optical NetworksPanel: Future Wireless Extensions of Regional Optical Networks
Panel: Future Wireless Extensions of Regional Optical Networks
 
Global Research Platform Workshops - Maxine Brown
Global Research Platform Workshops - Maxine BrownGlobal Research Platform Workshops - Maxine Brown
Global Research Platform Workshops - Maxine Brown
 
Built around answering questions
Built around answering questionsBuilt around answering questions
Built around answering questions
 
Panel: NRP Science Impacts​
Panel: NRP Science Impacts​Panel: NRP Science Impacts​
Panel: NRP Science Impacts​
 
Democratizing Science through Cyberinfrastructure - Manish Parashar
Democratizing Science through Cyberinfrastructure - Manish ParasharDemocratizing Science through Cyberinfrastructure - Manish Parashar
Democratizing Science through Cyberinfrastructure - Manish Parashar
 
Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;
Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;
Panel: Building the NRP Ecosystem with the Regional Networks on their Campuses;
 
Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...
Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...
Open Force Field: Scavenging pre-emptible CPU hours* in the age of COVID - Je...
 
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
 
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
 
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
Panel: Open Infrastructure for an Open Society: OSG, Commercial Clouds, and B...
 
Frank Würthwein - NRP and the Path forward
Frank Würthwein - NRP and the Path forwardFrank Würthwein - NRP and the Path forward
Frank Würthwein - NRP and the Path forward
 

Dynamics of the Interaction Between the Human Gut Microbiome and Immune System

  • 1. “Dynamics of the Interaction Between the Human Gut Microbiome and Immune System” Discussion Janssen La Jolla Research and Development La Jolla, CA February 22, 2013 Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E. Gruber Professor, Dept. of Computer Science and Engineering 1 Jacobs School of Engineering, UCSD
  • 2. From Measuring Macro-Variables to Measuring Your Internal Variables www.technologyreview.com/biomedicine/39636
  • 3. From One to a Billion Data Points Defining Me: The Exponential Rise in Body Data in Just One Decade! Billion:Microbial Genome My Full DNA, MRI/CT Images Improving Body SNPs Million: My DNA SNPs, Zeo, FitBit Discovering Disease Blood Variables One: Hundred: My Blood Variables Weight Weight My
  • 4. Visualizing Time Series of 150 LS Blood and Stool Variables, Each Over 5 Years Calit2 64 megapixel VROOM
  • 5. Complex Reactive Protein From Blood Sample 27x Upper Limit Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Range <1 mg/L Antibiotics Antibiotics Normal
  • 6. Lactoferrin From Stool Sample 124x Upper Limit Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Range Antibiotics <7.3 µg/mL Antibiotics
  • 7. High Lactoferrin Biomarker Led Me to Hypothesis I Had Inflammatory Bowel Disease (IBD) IBD is an Autoimmune Disease Which Comes in Two Subtypes: Crohn’s and Ulcerative Colitis Scand J Gastroenterol. 42, 1440-4 (2007) My Values May 2011 My Values 2009-10 High Level of Calprotectin Confirmed Hypothesis
  • 8. Colonoscopy Images Show Sigmoid Colon Inflammation Dec 2010 May 2011
  • 9. Confirming the IBD (Crohn’s) Hypothesis: Finding the “Smoking Gun” with MRI Imaging Liver I Obtained the MRI Slices Transverse Colon From UCSD Medical Services and Converted to Interactive 3D Working With Small Intestine Calit2 Staff & DeskVOX Software Descending Colon MRI Jan 2012 Cross Section Diseased Sigmoid Colon Major Kink Sigmoid Colon Threading Iliac Arteries
  • 10. Comparison of DeskVOX with Clinical MRI Slice Program
  • 11. Interactively Exploring My Body With Calit2 Virtual Reality Facilities TourCAVE StarCAVE VROOM www.youtube.com/watch?v=9c4DtJ_L_Ps zSpace Photo & CalVR software Courtesy of Jurgen Schulze, Calit2
  • 12. Connecting Colonoscopy “Inside View” With MRI “Outside View” LS Colon Images and Colonoscopy Video On Calit2 Director’s Colony OptIPortable Wall
  • 13. Why Did I Have an Autoimmune Disease like IBD? Despite decades of research, the etiology of Crohn's disease remains unknown. Its pathogenesis may involve a complex interplay between host genetics, immune dysfunction, and microbial or environmental factors. --The Role of Microbes in Crohn's Disease So I Set Out to Quantify All Three! Paul B. Eckburg & David A. Relman Clin Infect Dis. 44:256-262 (2007) 
  • 14. I Wondered if Crohn’s is an Autoimmune Disease, Did I Have a Personal Genomic Polymorphism? From www.23andme.com Polymorphism in Interleukin-23 Receptor Gene — 80% Higher Risk ATG16L1 of Pro-inflammatory Immune Response IRGM NOD2 SNPs Associated with CD Now Comparing 163 Known IBD SNPs with 23andme SNP Chip
  • 15. Crohn’s May be a Related Set of Diseases Driven by Different SNPs NOD2 (1) rs2066844 Female CD Onset At 20-Years Old Il-23R rs1004819 Me-Male CD Onset At 60-Years Old
  • 16. White Blood Cell Count From Blood Sample Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Range 4-10,000 cells/µL Normal Antibiotics
  • 17. Neutrophils as % of WBCs From Blood Sample Normal Range 31-71% Normal Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11
  • 18. Lymphocytes as % of WBCs From Blood Sample Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Antibiotics Lymphocytes Include B Cells, T cells, and Natural Killer Cells
  • 19. Eosinophils as % of WBCs From Blood Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Normal Range 1-7% Antibiotics
  • 20. Monocytes as % of WBCs From Blood Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Normal Range 5-12%
  • 21. Calprotectin From Stool Sample 50x Upper Limit Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Range <50 µg/g Antibiotics
  • 22. Secretory IgA From Stool Sample 7x Upper Limit Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Antibiotics Antibiotics Normal Range 54-204 mg/dL Normal
  • 23. Lysozyme From Stool Sample 2x Upper Limit Antibiotics Antibiotics Peak Sec IgA, Lysozyme 1/30/12 Peak CRP, Calprotectin 12/28/11 Peak Lactoferrin 5/2/11 Normal Normal Range <600 ng/mL
  • 24. Putting Multiple Immunological Biomarker Time Series Together, Reveals Major Immune Dysfunction Green : Inside Range Orange: 1-10x Over Red: 10-100x Over Purple: >100x Over Source: Calit2 Future Health Expedition Team
  • 25. Four Immune Biomarkers Over Time Compared with Four Signs/Symptoms Here Immune biomarkers are normalized 0 to 1, with 1 being the highest value in five years Source: Photo of Calit2 64-megapixel VROOM
  • 26. Microbes are 90% of Your Cells-So I Set Out to Determine My Gut Microbes & Their Time Variation Shipped Stool Sample December 28, 2011 I Received a Disk Drive April 3, 2012 With 35 GB FASTQ Files Weizhong Li, UCSD NGS Pipeline: 230M Reads Only 0.2% Human Required 1/2 cpu-yr at SDSC Per Person Analyzed!
  • 27. First Surprise: Almost All My DNA Abundances are Viral!
  • 28. LS Viral Species Comprise >97% Relative Abundance of Virus + Bacteria + Archaea LS Virus Species Which Are >1% of Total Abundance In an Average Healthy Person, None of LS Viruses Exceed 0.01% of the Total Relative Abundance of Viruses + Bacteria In Average Healthy Person, Viruses Are <2% of Total Abundance
  • 29. My Viral Load is Mainly SP-6 Like
  • 30. What is a “Healthy” Gut Microbiome? Considerable Phyla Variation Found in HMP Note: Euryarchaeota Are So Rare That They Arent Graphed! Source: “Structure, function and diversity of the healthy human microbiome,” HMP Consortium, Nature, 486, 207-212 (2012)
  • 31. Phyla Gut Microbial Abundance Without Viruses: LS, Crohn’s, UC, and Healthy Subjects Source: Weizhong Li, UCSD; Calit2 FuturePatient Expedition LS Crohn’s Ulcerative Healthy Colitis Toward Noninvasive Microbial Ecology Diagnostics
  • 32. LS Time Series Gut Microbiome Classes vs. Healthy, Crohn’s, Ulcerative Colitis
  • 33. Microbial Metagenomics Can Diagnose Disease States Using Principal Component Analysis From www.23andme.com Mutation in Interleukin-23 Receptor Gene—80% Higher Risk of Pro-inflammatory Immune Response IBD Patients Harbored, on Average, 25% Fewer SNPs Associated with CD Microbial Genes than the Individuals Not Suffering from IBD. 2009
  • 34. Principal Component Analysis On Microbial Species Abundance
  • 35. Healthy, CD, UC and LS Relative Abundance of Proteobacteria to Actinobacteria
  • 36. Bacteroides fragilis Levels Different For Healthy and IBD Human Gut-Differentiates CD and UC Healthy Ulcerative Colitis LS Crohn’s Disease Source: Analysis by LS working on Weizhong Li Data
  • 37. Almost All Abundant Species (≥1%) in Healthy Subjects Are Severely Depleted in LS Gut
  • 38. Top 20 Most Abundant Microbial Species In LS vs. Average Healthy Subject 152x Number Above LS Blue Bar is Multiple of LS Abundance 765x Compared to Average 148x Healthy Abundance Per Species 849x 483x 220x 201x169x 522x Source: Sequencing JCVI; Analysis Weizhong Li, UCSD LS December 28, 2011 Stool Sample
  • 39. Comparing 3 LS Time Snapshots (Left) with Healthy, Crohn’s, UC (Right Top to Bottom) Calit2 VROOM-FuturePatient Expedition
  • 40. LS Gut Microbe Species 12/28/11 (red) compared to Average of 35 Healthy Subjects (blue) Derived from metagenomic sequencing of LS stool sample. Each species is a bar, height is logarithmic abundance, species are divided into microbial phyla Source: Photo of Calit2 64-megapixel VROOM
  • 41. 200 LS Gut Microbe Species at 3 Times 12/28/11, 4/3/12, 8/7/12 Red is at Highest Value of CRP Blue is the Day After End of Antibiotic/Prednisone Therapy Green is Four Months Later Source: Photo of Calit2 64-megapixel VROOM
  • 42. Closeup of Uncommon LS Microbes 12/28/11 Stool Sample Two separate 45x research teams Reduced have found strikingly high By 8% 90x concentrations Therapy Increased Reduced of Fusobacterium in tumor samples By By collected from Therapy Therapy colorectal cancer patients. October 18, 2011
  • 43. From War to Gardening “I would like to lose the language of warfare,” said Julie Segre, a senior investigator at the National Human Genome Research Institute. ”It does a disservice to all the bacteria that have co-evolved with us and are maintaining the health of our bodies.”
  • 44. DIY Systems Biology - Toward P4 Healthcare Over 1000 Downloads So Far Download pdfs from Journal: http://onlinelibrary.wiley.com/doi/10.1002/biot.201100495/full
  • 45. Integrative Personal Omics Profiling Reveals Details of Clinical Onset of Viruses and Diabetes Cell 148, 1293–1307, March 16, 2012 • Michael Snyder, Chair of Genomics Stanford Univ. • Genome 140x Coverage • Blood Tests 20 Times in 14 Months – tracked nearly 20,000 distinct transcripts coding for 12,000 genes – measured the relative levels of more than 6,000 proteins and 1,000 metabolites in Snyder's blood